Drug Pipeline

Treprostinil Palmitil Inhalation Powder Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
2
Recruiting
4
Phase 3
1
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-28 NCT07179380
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in…
Trial sites expanded: 96 -> 109 locations
2026-05-27 NCT07481981
A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil…
Recruitment opened
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-06-11 NCT07643155 A Study to Evaluate the Pharmacokinetics (PK) and Safety of a Single Dose of Treprostinil… Phase 1 Not Yet Recruiting
Active Studies by Phase
Phase 3
3
Phase 2/3
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07179380 Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in… Pulmonary Hypertension Recruiting
NCT07481981 A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil… Pulmonary Arterial Hypertension Recruiting
NCT07234032 An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in… Pulmonary Hypertension Not Yet Recruiting
Phase 2/3
NCT05649748 An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary… Pulmonary Arterial Hypertension Active, Not Recruiting
Phase 1
NCT07643155 A Study to Evaluate the Pharmacokinetics (PK) and Safety of a Single Dose of Treprostinil… Hepatic Impairment Not Yet Recruiting
Sponsors Running Treprostinil Palmitil Inhalation Powder Trials
Disease Areas
Get alerts when Treprostinil Palmitil Inhalation Powder trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free